Edition:
United Kingdom

Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

23.80USD
23 Aug 2019
Change (% chg)

$-2.22 (-8.53%)
Prev Close
$26.02
Open
$25.92
Day's High
$25.92
Day's Low
$23.79
Volume
72,460
Avg. Vol
17,475
52-wk High
$38.48
52-wk Low
$19.43

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.57 December 24 Aug 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 8 0.96 2.00 0.00 3.17
Quarter Ending Dec-19 8 1.25 3.00 0.00 4.00
Year Ending Dec-19 8 3.80 6.82 0.00 8.63
Year Ending Dec-20 8 13.78 36.09 0.00 30.20
Earnings (per share)
Quarter Ending Sep-19 8 -1.57 -1.35 -1.72 -1.04
Quarter Ending Dec-19 8 -1.67 -1.29 -2.00 -1.23
Year Ending Dec-19 8 -5.97 -5.43 -6.36 -3.65
Year Ending Dec-20 8 -5.80 -4.84 -7.07 -3.61

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-19 0.77 1.25 0.48 63.06
Quarter Ending Mar-19 0.97 0.57 0.40 41.48
Quarter Ending Dec-18 1.14 0.57 0.57 50.11
Quarter Ending Sep-18 0.89 0.24 0.65 73.42
Quarter Ending Jun-18 0.57 0.73 0.16 27.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 0.96 0.96 0.92 0.92 3.17
Quarter Ending Dec-19 1.25 1.25 1.28 1.28 4.00
Year Ending Dec-19 3.80 3.80 3.47 3.47 8.63
Year Ending Dec-20 13.78 13.78 14.96 14.96 30.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 1 0
Quarter Ending Dec-19 0 0 0 1
Year Ending Dec-19 0 0 4 1
Year Ending Dec-20 0 0 2 1
Earnings